Enteroendocrine Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Enteroendocrine cells (EECs) are specialized hormone-producing epithelial cells dispersed throughout the gastrointestinal tract. They constitute the largest endocrine organ in the body and play critical roles in regulating digestion, appetite, glucose metabolism, and gut-brain communication. These cells are emerging as important players in neurodegenerative diseases through their effects on systemic metabolism and the gut-brain axis.
¶ Anatomy and Distribution
¶ Location and Distribution
- Distributed throughout the gastrointestinal tract
- Most abundant in the small intestine and colon
- Represent less than 1% of epithelial cells but have extensive contact with gut lumen
| Cell Type |
Location |
Primary Hormone |
Functions |
| K cells |
Duodenum, jejunum |
GIP, GLP-1 |
Incretin effect, glucose metabolism |
| L cells |
Ileum, colon |
GLP-1, PYY, Oxyntomodulin |
Satiety, glucose regulation |
| I cells |
Duodenum, jejunum |
CCK |
Pancreatic secretion, satiety |
| S cells |
Duodenum |
Secretin |
Pancreatic bicarbonate |
| G cells |
Stomach |
Gastrin |
Gastric acid secretion |
| Enterochromaffin cells |
Stomach, intestine |
Serotonin |
Motility, platelet function |
| M cells |
Duodenum |
Motilin |
GI motility |
| D cells |
Stomach, intestine |
Somatostatin |
Inhibits other hormones |
| N cells |
Ileum |
Neurotensin |
GI motility, inflammation |
Enteroendocrine cells respond to nutrients in the gut lumen and secrete hormones that act on:
- Paracrine effects - Act on nearby cells
- Endocrine effects - Travel through bloodstream to distant targets
- Neurocrine effects - Signal to enteric nervous system
¶ Key Hormones and Their Functions
- Enhances glucose-stimulated insulin secretion
- Inhibits glucagon release
- Promotes satiety
- Slows gastric emptying
- Neuroprotective effects
- Stimulates gallbladder contraction
- Pancreatic enzyme secretion
- Promotes satiety
- Modulates anxiety and memory
- Inhibits food intake
- Slows gastric emptying
- Reduces intestinal motility
- Regulates gut motility
- Platelet function
- Mood regulation (via gut-brain axis)
- Nausea and vomiting reflexes
EECs express various nutrient receptors:
- Sweet taste receptors (T1R2/T1R3)
- Fatty acid receptors (FFAR1-4, GPR120)
- Amino acid receptors (CaSR, GPRC6A)
- G-protein coupled receptors for various nutrients
- Vagus nerve: EECs signal to vagal afferents
- Enteric nervous system: Direct communication with enteric neurons
- Spinal afferents: Nociceptive and mechanical signaling
- Hormones cross the blood-brain barrier
- Act on hypothalamic centers
- Influence appetite and metabolism
-
Metabolic Dysfunction:
- Type 2 diabetes increases AD risk
- GLP-1 and incretin signaling linked to neuroprotection
- Insulin resistance in AD brain
-
Gut Hormone Alterations:
- Altered GLP-1 levels in AD patients
- CCK deficits may affect cognition
-
Therapeutic Implications:
- GLP-1 agonists (liraglutide, semaglutide) in clinical trials for AD
- Incretin-based therapies show promise
-
Gut-Brain Axis:
- EECs may contribute to α-synuclein misfolding
- Altered serotonin in PD depression
- Motilin abnormalities in PD GI dysmotility
-
Metabolic Connections:
- Diabetes comorbidity with PD
- GLP-1 effects on dopaminergic neurons
-
Therapeutic Potential:
- GLP-1 agonists explored for neuroprotection
- Targeting gut hormone signaling
-
Metabolic Dysfunction:
- Hypermetabolism in ALS
- Altered gut hormones correlate with prognosis
-
Therapeutic Approaches:
- GLP-1 agonists under investigation
¶ Mood and Psychiatric Symptoms
- Serotonin dysregulation in depression
- CCK in anxiety disorders
- PYY in stress response
- Relevant to neuropsychiatric symptoms in neurodegeneration
- CHGA (Chromogranin A)
- CHGB (Chromogranin B)
- SCT (Secretin)
- GAST (Gastrin)
- CCK (Cholecystokinin)
- PYY (Peptide YY)
- GCG (Glucagon)
- TPH1 (Tryptophan hydroxylase 1) - for serotonin cells
-
GLP-1 Agonists:
- Liraglutide, semaglutide, dulaglutide
- Neuroprotective potential in AD and PD
-
CCK-Based Therapies:
- CCK agonists for memory enhancement
-
Serotonin Modulation:
- SSRIs affect gut and brain serotonin
-
Dietary Interventions:
- Prebiotics and probiotics affect EEC function
- Fiber influences GLP-1 secretion
The study of Enteroendocrine Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Gribble FM, Reimann F. (2019). "Function and mechanisms of enteroendocrine cells and gut hormones in metabolism." Nat Rev Endocrinol. 15(4):226-237.
2.ps E. (2019). "Enteroendocrine cells: chemosensors in the intestinal epithelium." Annu Rev Physiol. 78:277-299.
- Holst JJ. (2007). "The physiology of glucagon-like peptide 1." Physiol Rev. 87(4):1409-1439.
- Sanger GJ, Lee K. (2008). "Hormones of the gut-brain axis as targets for the treatment of upper GI disorders." Nat Rev Drug Discov. 7(3):241-254.
- Camilleri M, et al. (2012). "Human gastric acid secretion and permeability to oral agents." Clin Pharmacol Ther. 91(5):804-812.
- Braak H, et al. (2003). "Staging of brain pathology related to sporadic Parkinson's disease." Neurobiol Aging. 24(2):197-211.
- Holmqvist S, et al. (2014). "Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats." Acta Neuropathol. 128(6):805-820.